# A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.

> **NCT00261430** · PHASE4 · COMPLETED · sponsor: **Janssen, LP** · enrollment: 650 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **BEHAVIORAL:** GAIN Acceptance Approach

## Key facts

- **NCT ID:** NCT00261430
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261430, "A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00261430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*